BIOMAT Database Logo BIOMAT Database Logo

Polymyxin B with dual carbapenem combination therapy against carbapenemase-producing Klebsiella pneumoniae. 2015

Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
Department of Pharmacy, Singapore General Hospital, Outram Road, Singapore 169608, Singapore.

UI MeSH Term Description Entries
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D003091 Colistin Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally. Polymyxin E,Colimycin,Colisticin,Colistin Sulfate,Coly-Mycin,Totazina,Sulfate, Colistin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D016470 Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Bacteremias
D024901 Drug Resistance, Multiple, Bacterial The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Drug Resistance, Extensive, Bacterial,Drug Resistance, Extensively, Bacterial,Extensive Antibacterial Drug Resistance,Extensively Antibacterial Drug Resistance,Multidrug Resistance, Bacterial,Multiple Antibacterial Drug Resistance,Bacterial Multidrug Resistance,Bacterial Multidrug Resistances,Resistance, Bacterial Multidrug

Related Publications

Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection.
February 2019, International journal of antimicrobial agents,
Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
February 2017, International journal of antimicrobial agents,
Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae.
June 2011, Antimicrobial agents and chemotherapy,
Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae.
February 2017, Antimicrobial agents and chemotherapy,
Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
In Vitro Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae.
July 2017, Antimicrobial agents and chemotherapy,
Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.
August 2011, Diagnostic microbiology and infectious disease,
Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
Synergistic effects of Cinnamomum cassia L. essential oil in combination with polymyxin B against carbapenemase-producing Klebsiella pneumoniae and Serratia marcescens.
January 2020, PloS one,
Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.
March 2020, Clinical therapeutics,
Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
Polymyxin monotherapy versus polymyxin-based combination therapy against carbapenem-resistant Klebsiella pneumoniae: A systematic review and meta-analysis.
December 2020, Journal of global antimicrobial resistance,
Nathalie Grace Chua, and Yvonne Peijun Zhou, and Thuan Tong Tan, and Pushpalatha Bangalore Lingegowda, and Winnie Lee, and Tze Peng Lim, and Jocelyn Teo, and Yiying Cai, and Andrea L Kwa
Fosfomycin-meropenem synergistic combination against NDM carbapenemase-producing Klebsiella pneumoniae strains.
September 2023, The new microbiologica,
Copied contents to your clipboard!